blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP0915094

EP0915094 - MORPHINANE DERIVATIVES AND MEDICINAL USE THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  12.09.2008
Database last updated on 03.09.2024
Most recent event   Tooltip06.03.2009Lapse of the patent in a contracting state
New state(s): FI, GR		published on 08.04.2009  [2009/15]
Applicant(s)For all designated states
TORAY INDUSTRIES, INC.
2-1, Nihonbashi Muromachi 2-chome, Chuo-ku
Tokyo 103-8666 / JP
[2007/45]
Former [1999/19]For all designated states
TORAY INDUSTRIES, INC.
2-1, Nihonbashi-Muromachi 2-chome, Chuo-ku
Tokyo 103-8666 / JP
Inventor(s)01 / NAGASE, Hiroshi
2-10-4, Kajiwara Kamakura-shi
Kanagawa 247-0063 / JP
02 / FUJII, Hideaki
N-101, 1-31-17, Tsunishi Kamakura-shi
Kanagawa 248-0034 / JP
03 / ENDOH, Takashi
1586-4, Hagizono Chigasaki-shi
Kanagawa 253-0071 / JP
04 / KAWAI, Koji
L-202, 2-1-20, Tsunishi Kamakura-shi
Kanagawa 248-0034 / JP
[1999/19]
Representative(s)Webster, Jeremy Mark, et al
Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[N/P]
Former [2007/26]Webster, Jeremy Mark, et al
Mewburn Ellis LLP York House 23 Kingsway London
WC2B 6HP / GB
Former [1999/19]Coleiro, Raymond, et al
MEWBURN ELLIS York House 23 Kingsway
London WC2B 6HP / GB
Application number, filing date98911044.027.03.1998
[1999/19]
WO1998JP01376
Priority number, dateJP1997007634027.03.1997         Original published format: JP 7634097
[1999/19]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9843978
Date:08.10.1998
Language:EN
[1998/40]
Type: A1 Application with search report 
No.:EP0915094
Date:12.05.1999
Language:EN
The application published by WIPO in one of the EPO official languages on 08.10.1998 takes the place of the publication of the European patent application.
[1999/19]
Type: B1 Patent specification 
No.:EP0915094
Date:07.11.2007
Language:EN
[2007/45]
Search report(s)International search report - published on:JP08.10.1998
(Supplementary) European search report - dispatched on:EP06.08.2004
ClassificationIPC:C07D489/12, A61K31/485
[1999/19]
CPC:
C07D489/12 (EP,KR,US); A61K31/485 (KR)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   NL,   PT,   SE [1999/19]
TitleGerman:Morphinanderivate und ihre medizinische Anwendung[1999/19]
English:MORPHINANE DERIVATIVES AND MEDICINAL USE THEREOF[1999/19]
French:DERIVES DE MORPHINANE ET USAGE MEDICAL DE CES DERNIERS[1999/19]
Entry into regional phase17.12.1998Translation filed 
18.12.1998National basic fee paid 
18.12.1998Search fee paid 
18.12.1998Designation fee(s) paid 
18.12.1998Examination fee paid 
Examination procedure18.12.1998Examination requested  [1999/19]
19.05.2006Despatch of a communication from the examining division (Time limit: M06)
28.11.2006Reply to a communication from the examining division
15.12.2006Despatch of a communication from the examining division (Time limit: M04)
02.03.2007Reply to a communication from the examining division
18.05.2007Communication of intention to grant the patent
24.09.2007Fee for grant paid
24.09.2007Fee for publishing/printing paid
Opposition(s)08.08.2008No opposition filed within time limit [2008/42]
Fees paidRenewal fee
22.03.2000Renewal fee patent year 03
22.03.2001Renewal fee patent year 04
22.03.2002Renewal fee patent year 05
24.03.2003Renewal fee patent year 06
23.03.2004Renewal fee patent year 07
22.03.2005Renewal fee patent year 08
22.03.2006Renewal fee patent year 09
22.03.2007Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT07.11.2007
BE07.11.2007
CH07.11.2007
DK07.11.2007
FI07.11.2007
LI07.11.2007
NL07.11.2007
SE07.02.2008
GR08.02.2008
IE27.03.2008
PT07.04.2008
[2009/13]
Former [2009/08]AT07.11.2007
BE07.11.2007
CH07.11.2007
DK07.11.2007
LI07.11.2007
NL07.11.2007
SE07.02.2008
IE27.03.2008
PT07.04.2008
Former [2008/42]AT07.11.2007
BE07.11.2007
CH07.11.2007
DK07.11.2007
LI07.11.2007
NL07.11.2007
SE07.02.2008
PT07.04.2008
Former [2008/40]AT07.11.2007
BE07.11.2007
CH07.11.2007
DK07.11.2007
LI07.11.2007
NL07.11.2007
SE07.02.2008
Former [2008/35]AT07.11.2007
CH07.11.2007
DK07.11.2007
LI07.11.2007
NL07.11.2007
SE07.02.2008
Former [2008/29]AT07.11.2007
CH07.11.2007
LI07.11.2007
NL07.11.2007
SE07.02.2008
Former [2008/23]CH07.11.2007
LI07.11.2007
NL07.11.2007
SE07.02.2008
Documents cited:Search[A]  - LESSOR, RALPH A. ET AL, "Probes for narcotic receptor mediated phenomena. 13. Potential irreversible narcotic antagonist-based ligands derived from 6,14-endo-ethenotetrahydrooripavine with 7-(methoxyfumaroyl)amino, (bromoacetyl)amino, or isothiocyanate electrophiles: chemistry, biochemistry, and pharmacology", JOURNAL OF MEDICINAL CHEMISTRY , 29(11), 2136-41 CODEN: JMCMAR; ISSN: 0022-2623, (1986), XP002286998 [A] 1,9 * abstract *

DOI:   http://dx.doi.org/10.1021/jm00161a002
International search[Y]JPS4961188  ;
 [Y]JPS6163658  (DU PONT);
 [X]JPH03163083  (SEARLE & CO, et al);
 [Y]WO9315081  (TORAY INDUSTRIES [JP])
Examination   - ANALGESIA, (1995), vol. 1, no. 4-6, pages 647 - 650
    - ANALGESIA, (1995), vol. 1, no. 4-6, pages 386 - 389
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.